ORCL
Oracle Corporation
137.10$
-1.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +2.1% | +2.8% | +2.3% | +3.0% | +8.7% | +4.3% | +7.2% | +13.6% | +19.6% | +6.7% | +15.9% | |
| – | +9.2% | +7.1% | +2.3% | +1.9% | +28.1% | -18.4% | +0.2% | +39.5% | +59.7% | -15.1% | +19.5% | |
| – | +15.0% | +10.3% | +1.5% | +3.1% | +59.1% | -38.0% | -3.2% | +84.2% | +99.9% | -18.6% | +16.2% | |
| – | +14.0% | +7.6% | +2.3% | +3.7% | +57.6% | -37.1% | -1.8% | +79.6% | +98.0% | -18.5% | +16.3% | |
| – | +7.2% | +7.9% | +1.9% | +1.9% | -1.5% | +6.3% | +3.3% | +6.8% | +13.5% | -3.1% | +9.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | 0.0% | +0.0% | +0.0% | -0.1% | -0.1% | +0.1% | +0.0% | 0.0% | +0.1% | 0.0% | +0.0% | |
| – | -8.9% | -9.7% | -9.0% | -9.4% | -9.6% | -10.6% | -9.2% | -9.8% | -3.2% | -11.3% | – | |
| – | +0.7% | +0.6% | +0.9% | +1.0% | +7.4% | +2.3% | +5.7% | +12.0% | +18.1% | +6.1% | +7.9% | |
| – | +2.0% | +26.8% | +1.6% | -9.3% | +2.0% | +10.2% | +22.2% | -5.2% | +7.8% | +2.5% | +13.8% | |
| – | -12.8% | +92.5% | -13.2% | -11.3% | +0.1% | -11.0% | +24.9% | -10.9% | +63.4% | -45.6% | +5.9% | |
| – | +49.8% | +42.2% | -6.4% | +21.4% | -9.6% | +111.0% | +60.4% | +23.6% | -6.6% | +15.9% | +0.8% | |
| – | +0.0% | -7.5% | -1.2% | +6.8% | +9.5% | -3.2% | -3.6% | +21.6% | +24.7% | -1.9% | -3.8% | |
| – | +45.4% | +54.8% | +24.3% | +27.1% | +21.7% | +22.2% | +18.1% | +24.0% | +28.5% | +10.4% | +57.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.1% | +0.5% | +0.6% | +0.6% | +0.2% | -0.1% | +1.3% | +0.4% | -0.3% | +0.0% | +2.9% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.